Rapport Therapeutics, Inc. financial data

Symbol
RAPP on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2893% %
Debt-to-equity 5.8% %
Return On Equity -29% % 15%
Return On Assets -27% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47,792,943 shares 31%
Common Stock, Shares, Outstanding 47,772,567 shares 31%
Entity Public Float $275,840,930 USD -42%
Common Stock, Value, Issued $48,000 USD 30%
Weighted Average Number of Shares Outstanding, Basic 38,934,569 shares 88%
Weighted Average Number of Shares Outstanding, Diluted 38,934,569 shares 88%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $94,789,000 USD 56%
General and Administrative Expense $30,310,000 USD 37%
Operating Income (Loss) $125,099,000 USD -51%
Nonoperating Income (Expense) $13,616,000 USD 187%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $17,537,000 USD -101%
Net Income (Loss) Attributable to Parent $111,483,000 USD -42%
Earnings Per Share, Basic -2.86 USD/shares 24%
Earnings Per Share, Diluted -2.86 USD/shares 24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $52,645,000 USD -7.3%
Cash, Cash Equivalents, and Short-term Investments $490,500,000 USD 61%
Assets, Current $498,561,000 USD 61%
Property, Plant and Equipment, Net $2,976,000 USD -16%
Operating Lease, Right-of-Use Asset $9,909,000 USD 587%
Other Assets, Noncurrent $985,000 USD 516%
Assets $512,431,000 USD 63%
Accounts Payable, Current $4,190,000 USD 114%
Employee-related Liabilities, Current $7,120,000 USD 92%
Accrued Liabilities, Current $12,104,000 USD 99%
Liabilities, Current $19,049,000 USD 117%
Operating Lease, Liability, Noncurrent $8,729,000 USD 1081%
Liabilities $27,778,000 USD 192%
Accumulated Other Comprehensive Income (Loss), Net of Tax $546,000 USD
Retained Earnings (Accumulated Deficit) $235,228,000 USD -90%
Stockholders' Equity Attributable to Parent $484,653,000 USD 59%
Liabilities and Equity $512,431,000 USD 63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,237,000 USD -15%
Net Cash Provided by (Used in) Financing Activities $63,659,000 USD
Net Cash Provided by (Used in) Investing Activities $21,031,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 47,772,567 shares 31%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $799,000 USD -81%
Deferred Tax Assets, Valuation Allowance $59,457,000 USD 97%
Deferred Tax Assets, Gross $62,002,000 USD 102%
Operating Lease, Liability $11,484,000 USD 678%
Depreciation $800,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $291,000 USD -73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $110,415,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid $13,415,000 USD 746%
Property, Plant and Equipment, Gross $4,958,000 USD 10%
Operating Lease, Liability, Current $2,755,000 USD 274%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,785,000 USD 264%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,478,000 USD 324%
Operating Lease, Weighted Average Discount Rate, Percent 0.0724 pure -0.69%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,931,000 USD 1655%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,861,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $10,195,000 USD 214%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,591,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $244,000 USD 61%
Share-based Payment Arrangement, Expense $18,855,000 USD 84%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%